Tender Details
Ref No 6369929
Document

Tender Notice

Bidding

Not specified

Short Description

Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Ustekinumab, Atc L04Ac05 (Obo) For The Period 01.08.2024 - 31.07.2025 (Plus Extension Option 1X12 Months)
Deadline *
Date 05 Jun 2026
* The estimated cost, values & dates are indicative only. Please read tender document for accurate information.
Client Address
Location Germany
More Information
Know More

FREE Trial Plan For All New Users!

Start your Business.

Similar Tenders

  • Ref No: 9232459
  • Location: United States

Ship Propulsion Fuel Bunkers

  • Deadline: 30 Sep 2025
  • Ref No: 8259327
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements According To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Cre 2 5 Mg N1

  • Deadline: 10 May 2026
  • Ref No: 8260726
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130 A Paragraph 8 Sgb V With The Active Ingredient Hydrocortisone Tab 10 Mg

  • Deadline: 10 May 2026
  • Ref No: 5304541
  • Location: Netherlands

Career Paths Construction Technology And Green

  • Deadline: 30 Apr 2026
  • Ref No: 5310892
  • Location: Germany

Drug Contracts With An Option To Join

  • Deadline: 01 May 2026

Dynamic Purchasing System Dis Rental Of New And Used Agricultural Machinery And Agricultural Implements

  • Deadline: 23 Apr 2034
  • Ref No: 5301821
  • Location: Bulgaria

Delivery Of Medicinal Products Which Are Included In Appendix 2 Of The Pds For The Needs Of Umbal Kanev Ad

  • Deadline: 27 May 2027
  • Ref No: 5301942
  • Location: Germany

Openhouse Procedure Dressing Materials

  • Deadline: 31 Aug 2026
  • Ref No: 5307616
  • Location: Netherlands

Career Paths Transport And Logistics

  • Deadline: 30 Apr 2026
  • Ref No: 5396790
  • Location: Germany

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient L

  • Deadline: 27 Apr 2026
  • Ref No: 4640403
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr

  • Deadline: 28 Feb 2026
  • Ref No: 4640423
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr

  • Deadline: 28 Feb 2026
  • Ref No: 4640900
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr

  • Deadline: 28 Feb 2026
  • Ref No: 4640967
  • Location: Germany

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingr

  • Deadline: 28 Feb 2026
  • Ref No: 4641405
  • Location: Germany

Medicines With The Active Ingredient Aclidinium Bromide Atc R03Bb05

  • Deadline: 28 Feb 2026